COsegregation of VARiants in Panel of Genes
Launched by INSTITUT CURIE · Sep 20, 2012
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The COsegregation of VARiants in Panel of Genes (COVAR) trial is studying how to better understand specific gene changes that may increase the risk of certain cancers. These changes, known as variants, can sometimes be unclear in terms of their significance, which is why this research aims to classify them accurately. The information gathered from this study will help doctors give better advice to patients and their families about managing their cancer risk, and in some cases, it could even lead to the recommendation of preventive surgeries.
To participate in this trial, you must be at least 18 years old and either have a specific gene variant linked to cancer (known as an "index case") or be a family member of someone who does. If you're selected, you'll be asked to provide written consent to take part in the study. The trial is currently looking for participants, and it's open to all genders. If you join, you can expect to help advance our understanding of genetic risks for cancer, which could ultimately benefit many families facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Index cases:
- • A person carrying a gene variant class 3 or 4, present and selected in the families of national database of genetic group and cancer (GGC Unicancer) which identifies the variations of all genes from the panel of genes of all French laboratories.
- • Age ≥ 18 years.
- • Signed written inform consent "index case"
- Related parties:
- • Any relative of an index case with cancer
- • Any relative without cancer related to an index case, retained by investigators, based on family structure and degree of related compared to the index case
- • Age ≥ 18 years
- • Information and signature of the informed consent "selected relatives"
- Exclusion Criteria:
- • Minors
- • Persons deprived of liberty or under guardianship (including curators).
- • Absence of signed written inform consent
About Institut Curie
Institut Curie is a prestigious French research institute dedicated to the fight against cancer, renowned for its integration of cutting-edge research, innovative therapies, and comprehensive patient care. Established in 1909, it combines academic excellence with clinical expertise, facilitating groundbreaking studies and clinical trials aimed at advancing cancer treatment and improving patient outcomes. With a multidisciplinary approach, Institut Curie collaborates with leading scientists and healthcare professionals, fostering a dynamic environment for the development of novel therapeutic strategies and personalized medicine in oncology. Its commitment to research and patient-centered care positions Institut Curie as a pivotal player in the global cancer research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, , France
Clermont Ferrand, , France
Paris, , France
Tours, , France
Paris, , France
Vandoeuvre Les Nancy, , France
Paris, , France
Grenoble, , France
Marseille, , France
Paris, , France
Limoges, , France
Villejuif, , France
Rennes, , France
Bordeaux, , France
Lille, , France
Marseille, , France
Rouen, , France
Bordeaux, , France
Colmar, , France
Paris, , France
Lille, , France
Lyon, , France
Niort, , France
Orléans, , France
Caen, , France
Le Havre, , France
Poitiers, , France
Montpellier, , France
Nantes, , France
Reims, , France
Valence, , France
Reims, , France
Dijon, , France
Lyon, , France
Saint Cloud, Haut De Seine, France
Paris, Ile De France, France
Amiens, , France
Angers, , France
Angoulême, , France
Avignon, , France
Besancon, , France
Bourges, , France
Brest, , France
Chambery, , France
La Rochelle, , France
Nîmes, , France
Reims, , France
Saint Herblain, , France
Saint étienne, , France
Strasbourg, , France
Strasbourg, , France
Toulouse, , France
Troyes, , France
Vandoeuvre Les Nancy, , France
Pointe à Pitre, , Guadeloupe
Fort De France, , Martinique
Saint Pierre, , Réunion
Patients applied
Trial Officials
Dominique STOPPA-LYONNET, PU-PH
Study Chair
Institut Curie
Sandrine CAPUTO, PhD
Study Director
Institut Curie
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials